CeleCor Therapeutics, Inc.
Industry: Pharmaceuticals (See others in industry)
Address:
1155 Camino Del Mar Suite 481
Del Mar, CA, 92014
Phone: 858-777-9750
Del Mar, CA, 92014
Phone: 858-777-9750
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-09 | New | $11,856,325 | $11,856,325 | Equity Only | 06b | SEC link |
| 2024-08-21 | Amended | $45,500,000 | $27,750,000 | Equity Only | 06b | SEC link |
| 2023-08-03 | Amended | $17,750,000 | $15,050,000 | Equity Only | 06b | SEC link |
| 2022-03-08 | New | $2,700,000 | $2,700,000 | Equity Only | 06b | SEC link |
| 2021-05-10 | New | $1,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| 2017-05-03 | New | $0 | $0 | Equity Only | 06b | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Peter B. Finn | Executive |
| Robert Hillman | Director, Executive |
| Robert S. Hillman, Ph.D. | Director, Executive |
| Jack Lief | Director |
| Andreas Ritzi | Director |
| Caspar F.V. Sturm | Director |